Laparoscopic colorectal surgery (LCS) was first described in the 1990s and for the most part has become the standard of care for colorectal surgery. Robotic-assisted colorectal surgery (RACS) was described around the year 2000, and advocates argue that it overcomes many issues associated with laparoscopic surgery, particularly in surgery for rectal cancer. More recently, the bottom-up minimally invasive approach, transanal total mesorectal excision (TaTME), for rectal surgery has gained popularity, and it has perceived advantages over laparoscopic rectal surgery.Minimally invasive surgery has been associated with some short-term benefits, including reduced bleeding and postoperative pain, and better cosmetic outcomes. Despite this, the debate on oncologic outcomes when compared with open surgery is still ongoing [1][2][3]. The benefits of one minimally invasive approach over the others form the subject of further debate, and as much of this is driven by proponents of an individual technique, choosing the most appropriate technique can be difficult [1,2]. Despite the enthusiasm of the proponents, many other factors play a part in the choice of technique and these can be broadly described as those related to the patient, surgeon and individual hospital or a country.We compared LCS, RACS and TaTME/TAMIS using the following criteria: (1) number of studies published in three time frames (I = within the first 2 years after acceptance of the technique; II = during the subsequent 3 years; III = 3 years after II, if available); (2) number of involved patients; (3) predicted/actual trends. We searched PubMed and only included randomized controlled trials, clinical trials, observational, case-control and cohort studies (time frames: laparoscopy